Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis

Scandinavian Journal of Urology and Nephrology
J M Giménez-BachsRicardo Sánchez-Prieto

Abstract

This study aimed to evaluate the usefulness of carbonic anhydrase IX (CA-IX) expression in clear cell renal cell carcinoma (CCRCC) using two different techniques to detect protein expression. An experimental, cross-sectional, analytical study was conducted to analyse proteins in renal tumour and healthy tissue specimens from 38 consecutive patients who underwent nephrectomy for renal cancer. CA-IX protein expression was measured by immunohistochemistry and Western blot analysis and quantified. Statistical analysis was performed with the positive and negative specific agreements and kappa coefficient. The sensitivity and specificity of both techniques were assessed. Statistical tests were conducted to analyse the association between CA-IX expression quantitation and normal prognosis factors (TNM stage and Fuhrman nuclear grade), only in CCRCC. The mean patient age was 65 years, 78.9% of patients were men and 57.9% of tumours were CCRCC. CA-IX protein expression was positive in 63.2% of tumours by immunohistochemistry and in 60.5% by Western blot. Both techniques detected CA-IX expression only in CCRCC and unclassifiable tumours. High concordance indices were observed for CCRCC diagnosis. Western blot and immunohistochemistry had...Continue Reading

References

Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Feb 21, 1998·Nucleic Acids Research·C BéroudC Junien
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·S V IvanovM I Lerman
May 11, 1999·JAMA : the Journal of the American Medical Association·W H ChowJ F Fraumeni
Jun 15, 1999·BJU International·Y MurakamiS Kagawa
Feb 12, 2000·Actas urologicas españolas·J Rubio BrionesE Solsona Narbón
Mar 10, 2001·The American Journal of Pathology·S IvanovE J Stanbridge
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hyung L KimArie S Belldegrun
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monica C PanelliFrancesco M Marincola
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael AtkinsSabina Signoretti
Jul 27, 2005·BJU International·John T LeppertArie S Belldegrun
Nov 22, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Jonathan Said
Jan 3, 2006·European Urology·José Miguel Giménez-BachsJulio A Virseda-Rodríguez
May 16, 2006·Urology·Andrew N YoungMahul B Amin
Jul 5, 2007·BJU International·Johanna SandlundTorgny Rasmuson
Sep 1, 2007·Current Opinion in Urology·Börje Ljungberg
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley C LeibovichEugene D Kwon
Dec 25, 2007·Advances in Anatomic Pathology·Andrew N YoungMahul B Amin
Apr 9, 2008·World Journal of Urology·Vincenzo FicarraWalter Artibani
Mar 10, 2009·Lancet·Brian I RiniBernard Escudier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.